Baidu
map
THER ADV OPHTHALMOL 润色咨询

Therapeutic Advances in Ophthalmology

出版年份:暂无数据 年文章数:186 投稿命中率: 开通期刊会员,数据随心看

出版周期:annual 自引率:暂无数据 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊简介

期刊简介
GetPortalImpactFactorByIdResp(projectId=1, id=e00423568, cover=https://img.medsci.cn/20231228/1703761362215_8538692.jpg, fullname=Therapeutic Advances in Ophthalmology , abbr=THER ADV OPHTHALMOL, pyear=暂无数据, frequence=annual, articleNumbers=186, citedSelf2015=null, acceptanceRate=null, submissionToAcceptance=null, averageReviewTime=暂无数据, reviewFee=null, pageFee=null, publishedRatio=2022年中国人文章占该期刊总数量100.00% , issn=2515-8414, greenSci=https://www.greensci.net/search?kw=2515-8414, scijournal=https://www.scijournal.org/impact-factor-of-THER-ADV-OPHTHALMOL.shtml, medsciHotlightString=null, medsciHotlightRealtime=1.372, medsciHotlight=0.255, medsciHotlight5year=0.052, citescore=4.5, hIndex=null, impactFactor=2.5, orgnization=Sage, orgnizationUrl=https://uk.sagepub.com/en-gb/asi/home?utm_source=wechat&utm_medium=SAGE_social&utm_campaign=WeChat_MedSci1103, country=USA, countryCn=美国, isOa=1, isOaString=是, sciScie=Clarivate Analytics: Emerging Sources Citation Index (ESCI) Directory of Open Access Journals (DOAJ) EBSCO ProQuest PubMed Central (PMC) Scopus, bigclassCas=null, smallclassCas=, website=https://journals.sagepub.com/home/OED?utm_source=wechat&utm_medium=SAGE_social&utm_campaign=MedSci, websiteHits=539, guideForAuthor=https://journals.sagepub.com/author-instructions/OED?utm_source=wechat&utm_medium=SAGE_social&utm_campaign=MedSci, guideForAuthorHits=520, submitWebsite=https://mc.manuscriptcentral.com/taop?utm_source=wechat&utm_medium=SAGE_social&utm_campaign=MedSci, submitWebsiteHits=202, content=<p>该刊是一本同行评审的开放获取期刊,提供最高质量的文章和综述,介绍眼科所有领域的开创性努力和创新研究。</p>, totalCites=466, brief=THER ADV OPHTHALMOL杂志暂不明确行业,暂不明确子行业的级别不明杂志, articleType=本刊接收类型不明, medsciHeat=<span style="color: #000000;">黑</span>, medsciComment=杂志水平一般,也很冷门,关注人少,审稿周期可能也不一定快,如果文章质量不佳,或时间不紧的话,可以考虑考虑。, medsciExplanation=MedSci期刊指数是根据中国科研工作者(含医学临床,基础,生物,化学等学科)对SCI杂志的认知度,熟悉程度,以及投稿的量等众多指标综合评定而成。当然,具体的,您还可以结合“<a href='//m.capotfarm.com/sci/submit.do?id=e00423568'>投稿经验系统</a>”,进行综合判断,这更是大家的实战经验,值得分享和参考。<br> 注意,上述MedSci期刊指数采用MedSci专利技术,由计算机系统自动计算,并给出建议,存在不准确的可能,仅供您投稿选择杂志时参考。, tags=null, citeScoreList=[GetImpactFactorCiteScoreListResponse(year=2023, citescore=4.5)], medsciIndexList=[GetImpactFactorMedsciIndexListResponse(year=2021, medsciHotlight=0.104), GetImpactFactorMedsciIndexListResponse(year=2022, medsciHotlight=0.453), GetImpactFactorMedsciIndexListResponse(year=2023, medsciHotlight=0.524), GetImpactFactorMedsciIndexListResponse(year=2024, medsciHotlight=1.372)], citeScoreGradeList=[], totalJcrAreaList=[], pmcUrl=https://www.ncbi.nlm.nih.gov/nlmcatalog?term=2515-8414[ISSN], pubmedUrl=https://www.ncbi.nlm.nih.gov/pubmed?cmd=search&term=Therapeutic Advances in Ophthalmology[ta], article_number=45, article_number_cn=1, earlyWarning=null, linkOutUrl=null, isJournalMember=false, unscrambleContent=null, dayViewCount=false, endexampletyle=暂无数据)
期刊名称
THER ADV OPHTHALMOL/Therapeutic Advances in Ophthalmology
ISSN
2515-8414
影响指数话题
预警等级
MedSci期刊指数
1.372 (MedSci实时期刊指数) | 0.052 (5年期刊指数)
CiteScore值
4.5
h-index
暂无数据
h5-median
暂无数据
出版社/管理机构
杂志由 Sage 出版或管理
出版国家/地区
USA 美国
出版周期
annual
出版年份
暂无数据
是否OA
被收录情况
Clarivate Analytics: Emerging Sources Citation Index (ESCI) Directory of Open Access Journals (DOAJ) EBSCO ProQuest PubMed Central (PMC) Scopus
JCR分区
暂无数据
中科院分区
大类:
小类:
Baidu
map
Baidu
map
Baidu
map